Search Results - "Lovley, Andrew"
-
1
Burden of hereditary transthyretin amyloidosis on quality of life
Published in Muscle & nerve (01-08-2019)“…ABSTRACT Introduction Hereditary transthyretin (hATTR) amyloidosis is a progressive, degenerative disease, with peripheral neuropathy, cardiomyopathy, and…”
Get full text
Journal Article -
2
The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy
Published in BMC neurology (17-03-2023)“…Patients with hereditary transthyretin amyloidosis (ATTRv) frequently experience symptoms of polyneuropathy (PN) that worsen over time and impair daily…”
Get full text
Journal Article -
3
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis
Published in Journal of neurology (01-04-2020)“…Objective To examine the impact on quality of life (QOL) of patients with hATTR amyloidosis with polyneuropathy treated with inotersen (Tegsedi™) versus…”
Get full text
Journal Article -
4
Patient-reported burden of hereditary transthyretin amyloidosis on functioning and well-being
Published in Journal of patient-reported outcomes (07-01-2021)“…Background Hereditary transthyretin (hATTR) amyloidosis is a rare, systemic, progressive, and life-threatening disease in which transthyretin proteins misfold…”
Get full text
Journal Article -
5
The Inflammatory Bowel Disease Questionnaire in Randomized Controlled Trials of Treatment for Ulcerative Colitis: Systematic Review and Meta-Analysis
Published in Journal of patient-centered research and reviews (27-04-2020)“…The 32-item Inflammatory Bowel Disease Questionnaire (IBDQ-32) is the most frequently used instrument to capture disease-specific quality of life in randomized…”
Get full text
Journal Article -
6
Qualitative research with patients and caregivers of patients with PIK3CA related overgrowth spectrum: content validity of clinical outcome assessments
Published in Journal of patient-reported outcomes (13-07-2022)“…Background PIK3CA-Related Overgrowth Spectrum (PROS) are rare syndromes caused by a mutation in the PIK3CA gene, including fibroadipose hyperplasia or…”
Get full text
Journal Article -
7
Qualitative and psychometric approaches to evaluate the PROMIS pain interference and sleep disturbance item banks for use in patients with rheumatoid arthritis
Published in Journal of patient-reported outcomes (06-07-2021)“…Background Patients with rheumatoid arthritis (RA) commonly experience pain despite the availability of disease-modifying treatments. Sleep disturbances are…”
Get full text
Journal Article -
8
Psychometric validation of the work productivity and activity impairment questionnaire in ulcerative colitis: results from a systematic literature review
Published in Journal of patient-reported outcomes (13-12-2018)“…Patients with ulcerative colitis, a type of inflammatory bowel disease, report negative impacts of disease symptoms on work-related outcomes, including…”
Get full text
Journal Article -
9
Responder Analysis for the Modified Neuropathy Impairment Score + 7 and the Norfolk-Quality of Life-Diabetic Neuropathy Questionnaire in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (4973)
Published in Neurology (14-04-2020)“…Abstract only…”
Get full text
Journal Article -
10
Long-Term Impact of Inotersen on Health-Related Quality-of-Life for Hereditary Transthyretin Amyloidosis with Polyneuropathy: NEURO-TTR Open-Label Extension at Two Years (4640)
Published in Neurology (14-04-2020)“…Abstract only…”
Get full text
Journal Article -
11
-
12
-
13
Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study
Published in Journal of neurology (01-01-2022)“…Objective Hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) is a rare disease characterized by rapid neuropathic progression. In pivotal…”
Get full text
Journal Article -
14
Increase in Polyneuropathy Disability Stage Does Not Predict Neuropathic Progression in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy Receiving Inotersen: Results from the NEURO-TTR Study (2333)
Published in Neurology (13-04-2021)“…Abstract only…”
Get full text
Journal Article -
15
Healthcare Resource Utilization And Disease Burden In Patients With Transthyretin Amyloidosis With Cardiomyopathy: Results From The Amyloidosis Research Consortium Transthyretin Amyloidosis Burden Of Illness Study
Published in Journal of cardiac failure (01-01-2024)“…Transthyretin amyloidosis (ATTR) is a rare and often fatal disease caused by the inappropriate folding of the protein, transthyretin, which deposits in the…”
Get full text
Journal Article -
16
A concept elicitation study to understand the relationship between sleep and pain in rheumatoid arthritis and axial spondyloarthritis
Published in Quality of life research (01-02-2024)“…Purpose This qualitative study (GSK study: 213635) was designed to better understand sleep disturbance as experienced by individuals with rheumatoid arthritis…”
Get full text
Journal Article -
17
-
18
Quality of Life (QOL) in Patients with Transthyretin Amyloidosis Accompanied by Peripheral Neuropathy (PN) (P3.9-062)
Published in Neurology (09-04-2019)“…Abstract only…”
Get full text
Journal Article -
19
-
20
Impact of Inotersen on Subgroups of Patients with Hereditary TTR Amyloidosis: Results from a Double-Blind Placebo-Controlled Trial
Published in Blood (29-11-2018)“…Background: Hereditary transthyretin amyloidosis (hATTR) is a rare, systemic, progressive, and fatal condition in which misfolded proteins, mainly produced in…”
Get full text
Journal Article